The Frequency and Clinical Implications of the BRAF Mutation in Papillary Thyroid Cancer Patients in Korea Over the Past Two Decades
BackgroundOver the past several decades, there has been a rapid worldwide increase in the prevalence of papillary thyroid cancer (PTC) as well as a number of changes in the clinicopathological characteristics of this disease. BRAFV600E, which is a mutation of the proto-oncogene BRAF, has become the...
Main Authors: | A Ram Hong, Jung Ah Lim, Tae Hyuk Kim, Hoon Sung Choi, Won Sang Yoo, Hye Sook Min, Jae Kyung Won, Kyu Eun Lee, Kyeong Cheon Jung, Do Joon Park, Young Joo Park |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Endocrine Society
2014-12-01
|
Series: | Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-29-505.pdf |
Similar Items
-
Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis
by: Woon Won Kim, et al.
Published: (2018-01-01) -
Concomitant BRAF Mutation in Hairy Cell Leukemia and Papillary Thyroid Cancer: Case Report
by: Shehab F. Mohamed, et al.
Published: (2019-12-01) -
The Impact of BRAF Mutation on the Recurrence of Papillary Thyroid Carcinoma: A Meta-Analysis
by: Xin Li, et al.
Published: (2020-07-01) -
Expressions of miRNAs in Papillary Thyroid Carcinoma and Their Associations with the BRAF Mutation and Clinicopathological Features
by: Song I Yang, et al.
Published: (2020-06-01) -
BRAF mutation in papillary thyroid microcarcinoma – additional marker of risk stratification
by: Dmitriy Yuriyevich Semyonov, et al.
Published: (2014-11-01)